Pharmaceutical Executive-12-01-2007

Pharmaceutical Executive

Financing the Future of Pharma

December 01, 2007

Features

0

0

Science is the lifeblood of pharma, of course. But these days, science isn't just what you produce in your own labs. It's what you can license, buy, partner on, or gain through acquisition. Which means that, increasingly, deals are the lifeblood of pharma.

Reach for the Radio

December 01, 2007

Column

0

0

In August, eMarketer reported that Internet ad sales had officially displaced radio ad sales, nabbing the slot of fourth-largest ad medium. That was a huge blow to radio, which receives a sizable chunk of ad dollars from the pharma industry. Now pharma marketers have a new option-ReachMD, a 24-hour satellite radio station that plays content targeted at doctors.

The Pharm Exec Pipeline Report 2007

December 01, 2007

Features

0

0

You couldn't call it a gusher, but the pipeline has still has some life in it, and important new therapies are working their way toward approval. Have we turned the corner? Judge for yourself, with the help of this guide to 61 of the best new products in development.

The $4 Billion Cyber Fraud

December 01, 2007

Column

0

0

The proof is in the metrics. Last June, MarkMonitor sifted through 60 million e-mail messages and billions of Web pages to get a handle on how six major brand-name drugs were being touted and sold on the Internet. In the process, it found nearly 3,200 online pharmacies selling those drugs, according to the Summer 2007 MarkMonitorBrandjacking Index. But only four-count 'em-of these e-stores carried the respected Verified Internet Pharmacy Practice Site (VIPPS) accreditation.

After the Crash

December 01, 2007

From the Editor

0

0

For several decades, pharma got the message that promotion could make consumers want to use new drugs. The system didn't work with Pfizer's Exubera. That's surprising news, but is it bad news?